SOLV
Solventum Corp
Key Financials
Net Income
$1.6B
↑ 224.8%
Revenue
$8.3B
↑ 0.9%
Operating Income
$2.2B
↑ 110.5%
Total Liabilities
$9.2B
↓ 19.6%
Gross Profit
$4.5B
↓ 3.1%
Shareholders' Equity
$5.0B
↑ 70.6%
EPS (Diluted)
$8.88
↑ 221.7%
Total Assets
$14.3B
↓ 1.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/20/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SOLV |
| Company Name | Solventum Corp |
| CIK | 1964738 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 651-733-1110 |